API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
94
PharmaCompass offers a list of Primaquine Diphosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Primaquine Diphosphate manufacturer or Primaquine Diphosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Primaquine Diphosphate manufacturer or Primaquine Diphosphate supplier.
PharmaCompass also assists you with knowing the Primaquine Diphosphate API Price utilized in the formulation of products. Primaquine Diphosphate API Price is not always fixed or binding as the Primaquine Diphosphate Price is obtained through a variety of data sources. The Primaquine Diphosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid, including repackagers and relabelers. The FDA regulates 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid supplier is an individual or a company that provides 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid active pharmaceutical ingredient (API) or 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid finished formulations upon request. The 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid suppliers may include 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid API manufacturers, exporters, distributors and traders.
click here to find a list of 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid DMF (Drug Master File) is a document detailing the whole manufacturing process of 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid active pharmaceutical ingredient (API) in detail. Different forms of 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid DMFs exist exist since differing nations have different regulations, such as 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid DMF submitted to regulatory agencies in the US is known as a USDMF. 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid USDMF includes data on 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid suppliers with USDMF on PharmaCompass.
A 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid CEP of the European Pharmacopoeia monograph is often referred to as a 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid Certificate of Suitability (COS). The purpose of a 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid to their clients by showing that a 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid CEP has been issued for it. The manufacturer submits a 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid CEP (COS) as part of the market authorization procedure, and it takes on the role of a 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid CEP holder for the record. Additionally, the data presented in the 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid DMF.
A 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid suppliers with CEP (COS) on PharmaCompass.
A 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid written confirmation (4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid WC) is an official document issued by a regulatory agency to a 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid manufacturer, verifying that the manufacturing facility of a 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid APIs or 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid finished pharmaceutical products to another nation, regulatory agencies frequently require a 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid WC (written confirmation) as part of the regulatory process.
click here to find a list of 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid suppliers with NDC on PharmaCompass.
4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid GMP manufacturer or 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid GMP API supplier for your needs.
A 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid CoA (Certificate of Analysis) is a formal document that attests to 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid's compliance with 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid specifications and serves as a tool for batch-level quality control.
4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid CoA mostly includes findings from lab analyses of a specific batch. For each 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid may be tested according to a variety of international standards, such as European Pharmacopoeia (4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid EP), 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid USP).